{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:04:23Z","timestamp":1772136263301,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T00:00:00Z","timestamp":1694217600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006313","name":"Barncancerfonden","doi-asserted-by":"publisher","award":["PR2020-0169"],"award-info":[{"award-number":["PR2020-0169"]}],"id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011759","name":"Str\u00e5ls\u00e4kerhetsmyndigheten","doi-asserted-by":"publisher","award":["SSM2020-2054"],"award-info":[{"award-number":["SSM2020-2054"]}],"id":[{"id":"10.13039\/501100011759","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009244","name":"Stockholm University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009244","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Evidence on the impact of chemotherapy on radiotherapy-induced second malignant neoplasms is controversial. We estimated how cisplatin modulates the in vitro response of two normal cell types to fractionated radiation. AHH-1 lymphoblasts and VH10 fibroblasts were irradiated at 1\u00a0Gy\/fraction 5 and 3 times per week during 12 and 19\u00a0days, respectively, and simultaneously treated with 0.1, 0.2, 0.4, 0.8, 1.7 and 3.3\u00a0\u00b5M of cisplatin twice a week. Cell growth during treatment was monitored. Cell growth\/cell death and endpoints related to accumulation of DNA damage and, thus, carcinogenesis, were studied up to 21\u00a0days post treatment in cells exposed to radiation and the lowest cisplatin doses. Radiation alone significantly reduced cell growth. The impact of cisplatin alone below 3.3\u00a0\u00b5M was minimal. Except the lowest dose of cisplatin in VH10 cells, cisplatin reduced the inhibitory effect of radiation on cell growth. Delayed cell death was highest in the combination groups while the accumulation of DNA damage did not reveal a clear pattern. In conclusion, fractionated, concomitant exposure to radiation and cisplatin reduces the inhibitory effect of radiation on cell proliferation of normal cells and does not potentiate delayed effects resulting from accumulation of DNA damage.<\/jats:p>","DOI":"10.1038\/s41598-023-39409-7","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T06:02:32Z","timestamp":1694239352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of fractionated cisplatin and radiation treatment on cell growth and accumulation of DNA damage in two normal cell types differing in origin"],"prefix":"10.1038","volume":"13","author":[{"given":"Pamela","family":"Akuwudike","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milagrosa","family":"L\u00f3pez-Riego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clo\u00e9","family":"Dehours","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lovisa","family":"Lundholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3951-774X","authenticated-orcid":false,"given":"Andrzej","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,9]]},"reference":[{"key":"39409_CR1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/ncponc0796","volume":"4","author":"L Kleinberg","year":"2007","unstructured":"Kleinberg, L., Gibson, M. K. & Forastiere, A. A. Chemoradiotherapy for localized esophageal cancer: Regimen selection and molecular mechanisms of radiosensitization. Nat. Clin. Pract. Oncol. 4, 282\u2013294. https:\/\/doi.org\/10.1038\/ncponc0796 (2007).","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"39409_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s10147-004-0443-z","volume":"9","author":"Y Nishimura","year":"2004","unstructured":"Nishimura, Y. Rationale for chemoradiotherapy. Int. J. Clin. Oncol. 9, 414\u2013420. https:\/\/doi.org\/10.1007\/s10147-004-0443-z (2004).","journal-title":"Int. J. Clin. Oncol."},{"key":"39409_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/02841860310004364","volume":"42","author":"L Marcu","year":"2003","unstructured":"Marcu, L., van Doorn, T. & Olver, I. Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer. Acta Oncol. 42, 315\u2013325. https:\/\/doi.org\/10.1080\/02841860310004364 (2003).","journal-title":"Acta Oncol."},{"key":"39409_CR4","doi-asserted-by":"publisher","first-page":"17505","DOI":"10.1021\/acs.jpcc.7b05271","volume":"121","author":"Y Dong","year":"2017","unstructured":"Dong, Y., Zhou, L., Tian, Q., Zheng, Y. & Sanche, L. Chemoradiation cancer therapy: Molecular mechanisms of cisplatin radiosensitization. J. Phys. Chem. C 121, 17505\u201317513. https:\/\/doi.org\/10.1021\/acs.jpcc.7b05271 (2017).","journal-title":"J. Phys. Chem. C"},{"key":"39409_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari, S. & BernardTchounwou, P. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur. J. Pharmacol. 740, 364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"39409_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.radonc.2014.04.001","volume":"111","author":"M Toulany","year":"2014","unstructured":"Toulany, M., Mihatsch, J., Holler, M., Chaachouay, H. & Rodemann, H. P. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition. Radiother. Oncol. 111, 228\u2013236. https:\/\/doi.org\/10.1016\/j.radonc.2014.04.001 (2014).","journal-title":"Radiother. Oncol."},{"key":"39409_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1158\/1541-7786.MCR-04-0032","volume":"3","author":"HJ Boeckman","year":"2005","unstructured":"Boeckman, H. J., Trego, K. S. & Turchi, J. J. Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining. Mol. Cancer Res. 3, 277\u2013285. https:\/\/doi.org\/10.1158\/1541-7786.MCR-04-0032 (2005).","journal-title":"Mol. Cancer Res."},{"key":"39409_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.pcl.2020.07.006","volume":"67","author":"M Hawkins","year":"2020","unstructured":"Hawkins, M. et al. Subsequent primary neoplasms: Risks, risk factors, surveillance, and future research. Pediatr. Clin. N. Am. 67, 1135\u20131154. https:\/\/doi.org\/10.1016\/j.pcl.2020.07.006 (2020).","journal-title":"Pediatr. Clin. N. Am."},{"key":"39409_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/nrc722","volume":"2","author":"S Bhatia","year":"2002","unstructured":"Bhatia, S. & Sklar, C. Second cancers in survivors of childhood cancer. Nat. Rev. Cancer 2, 124\u2013132. https:\/\/doi.org\/10.1038\/nrc722 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"39409_CR10","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1056\/nejm199206253262605","volume":"326","author":"RE Curtis","year":"1992","unstructured":"Curtis, R. E. et al. Risk of leukemia after chemotherapy and radiation treatment for breast cancer. N. Engl. J. Med. 326, 1745\u20131751. https:\/\/doi.org\/10.1056\/nejm199206253262605 (1992).","journal-title":"N. Engl. J. Med."},{"key":"39409_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/nejm199902043400504","volume":"340","author":"LB Travis","year":"1999","unstructured":"Travis, L. B. et al. Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N. Engl. J. Med. 340, 351\u2013357. https:\/\/doi.org\/10.1056\/nejm199902043400504 (1999).","journal-title":"N. Engl. J. Med."},{"key":"39409_CR12","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1200\/JCO.19.00129","volume":"37","author":"LM Turcotte","year":"2019","unstructured":"Turcotte, L. M. et al. Chemotherapy and risk of subsequent malignant neoplasms in the childhood cancer survivor study cohort. J. Clin. Oncol. 37, 3310\u20133319. https:\/\/doi.org\/10.1200\/JCO.19.00129 (2019).","journal-title":"J. Clin. Oncol."},{"key":"39409_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jama.290.4.465","volume":"290","author":"LB Travis","year":"2003","unstructured":"Travis, L. B. et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290, 465\u2013475. https:\/\/doi.org\/10.1001\/jama.290.4.465 (2003).","journal-title":"JAMA"},{"key":"39409_CR14","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1182\/asheducation-2016.1.323","volume":"323\u2013330","author":"FE van Leeuwen","year":"2016","unstructured":"van Leeuwen, F. E. & Ng, A. K. Long-term risk of second malignancy and cardiovascular disease after Hodgkin lymphoma treatment. Hematol. Am. Soc. Hematol. Educ. Program 323\u2013330, 2016. https:\/\/doi.org\/10.1182\/asheducation-2016.1.323 (2016).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"39409_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102709","author":"A Wegierek-Ciuk","year":"2021","unstructured":"Wegierek-Ciuk, A. et al. Cisplatin reduces the frequencies of radiotherapy-induced micronuclei in peripheral blood lymphocytes of patients with gynaecological cancer: Possible implications for the risk of second malignant neoplasms. Cells https:\/\/doi.org\/10.3390\/cells10102709 (2021).","journal-title":"Cells"},{"key":"39409_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21873\/anticanres.14746","volume":"41","author":"KS Rallis","year":"2021","unstructured":"Rallis, K. S., Lai Yau, T. H. & Sideris, M. Chemoradiotherapy in cancer treatment: Rationale and clinical applications. Anticancer Res. 41, 1\u20137. https:\/\/doi.org\/10.21873\/anticanres.14746 (2021).","journal-title":"Anticancer Res."},{"key":"39409_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ncponc0714","volume":"4","author":"TY Seiwert","year":"2007","unstructured":"Seiwert, T. Y., Salama, J. K. & Vokes, E. E. The concurrent chemoradiation paradigm\u2013general principles. Nat. Clin. Pract. Oncol. 4, 86\u2013100. https:\/\/doi.org\/10.1038\/ncponc0714 (2007).","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"39409_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canrad.2007.12.006","volume":"12","author":"RM Hermann","year":"2008","unstructured":"Hermann, R. M., Rave-Frank, M. & Pradier, O. Combining radiation with oxaliplatin: A review of experimental results. Cancer Radiother. 12, 61\u201367. https:\/\/doi.org\/10.1016\/j.canrad.2007.12.006 (2008).","journal-title":"Cancer Radiother."},{"key":"39409_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059 (2022).","journal-title":"Cancer Discov."},{"key":"39409_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112861","author":"P Akuwudike","year":"2022","unstructured":"Akuwudike, P. et al. Cell type-specific patterns in the accumulation of DNA Damage following multifractional radiation exposure. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232112861 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"39409_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0027-5107(95)00020-j","volume":"329","author":"SM Morris","year":"1995","unstructured":"Morris, S. M., Domon, O. E., McGarrity, L. J., Chen, J. J. & Casciano, D. A. Programmed cell death and mutation induction in AHH-1 human lymphoblastoid cells exposed to m-amsa. Mutat. Res. 329, 79\u201396. https:\/\/doi.org\/10.1016\/0027-5107(95)00020-j (1995).","journal-title":"Mutat. Res."},{"key":"39409_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/proteomes2030341","volume":"2","author":"O Loseva","year":"2014","unstructured":"Loseva, O. et al. Chronic low dose rate ionizing radiation exposure induces premature senescence in human fibroblasts that correlates with up regulation of proteins involved in protection against oxidative stress. Proteomes 2, 341\u2013362 (2014).","journal-title":"Proteomes"},{"key":"39409_CR23","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.semcancer.2021.03.017","volume":"81","author":"G Saini","year":"2022","unstructured":"Saini, G. et al. Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer. Semin. Cancer Biol. 81, 220\u2013231. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.017 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"39409_CR24","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1002\/1097-0142(197602)37:2+<1177::aid-cncr2820370829>3.0.co;2-3","volume":"37","author":"GJ D'Angio","year":"1976","unstructured":"D\u2019Angio, G. J. et al. Decreased risk of radiation-associated second malignant neoplasms in actinomycin-D-treated patients. Cancer 37, 1177\u20131185. https:\/\/doi.org\/10.1002\/1097-0142(197602)37:2+%3c1177::aid-cncr2820370829%3e3.0.co;2-3 (1976).","journal-title":"Cancer"},{"key":"39409_CR25","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1111\/j.1742-4658.2009.07331.x","volume":"276","author":"N Bitomsky","year":"2009","unstructured":"Bitomsky, N. & Hofmann, T. G. Apoptosis and autophagy: Regulation of apoptosis by DNA damage signaling\u2014roles of p53, p73 and HIPK2. FEBS J. 276, 6074\u20136083. https:\/\/doi.org\/10.1111\/j.1742-4658.2009.07331.x (2009).","journal-title":"FEBS J."},{"key":"39409_CR26","doi-asserted-by":"publisher","first-page":"e478s","DOI":"10.6061\/clinics\/2018\/e478s","volume":"73","author":"CRR Rocha","year":"2018","unstructured":"Rocha, C. R. R., Silva, M. M., Quinet, A., Cabral-Neto, J. B. & Menck, C. F. M. DNA repair pathways and cisplatin resistance: An intimate relationship. Clinics (Sao Paulo) 73, e478s. https:\/\/doi.org\/10.6061\/clinics\/2018\/e478s (2018).","journal-title":"Clinics (Sao Paulo)"},{"key":"39409_CR27","first-page":"68","volume":"3","author":"MV Alvarez","year":"1978","unstructured":"Alvarez, M. V., Cobreros, G., Heras, A. & Lopez Zumel, M. C. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br. J. Cancer Suppl. 3, 68\u201372 (1978).","journal-title":"Br. J. Cancer Suppl."},{"key":"39409_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/09553008914550851","volume":"55","author":"C Basham","year":"1989","unstructured":"Basham, C., Mills, J., Douple, E. B. & Roberts, J. J. The independent action of radiation and cisplatin on the survival or recovery of human normal or tumour cells in vitro or in vivo. Int. J. Radiat. Biol. 55, 807\u2013820. https:\/\/doi.org\/10.1080\/09553008914550851 (1989).","journal-title":"Int. J. Radiat. Biol."},{"key":"39409_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<635::AID-IJC23>3.0.CO;2-6","volume":"75","author":"R Gorodetsky","year":"1998","unstructured":"Gorodetsky, R., Levy-Agababa, F., Mou, X. & Vexler, A. M. Combination of cisplatin and radiation in cell culture: Effect of duration of exposure to drug and timing of irradiation. Int. J. Cancer 75, 635\u2013642 (1998).","journal-title":"Int. J. Cancer"},{"key":"39409_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/0360-3016(90)90226-a","volume":"19","author":"AC Begg","year":"1990","unstructured":"Begg, A. C. Cisplatin and radiation: Interaction probabilities and therapeutic possibilities. Int. J. Radiat. Oncol. Biol. Phys. 19, 1183\u20131189. https:\/\/doi.org\/10.1016\/0360-3016(90)90226-a (1990).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"39409_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1667\/RR3185.1","volume":"179","author":"M Rezaee","year":"2013","unstructured":"Rezaee, M., Sanche, L. & Hunting, D. J. Cisplatin enhances the formation of DNA single- and double-strand breaks by hydrated electrons and hydroxyl radicals. Radiat. Res. 179, 323\u2013331. https:\/\/doi.org\/10.1667\/RR3185.1 (2013).","journal-title":"Radiat. Res."},{"key":"39409_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/095530098141735","volume":"74","author":"JA Dolling","year":"1998","unstructured":"Dolling, J. A., Boreham, D. R., Brown, D. L., Mitchel, R. E. & Raaphorst, G. P. Modulation of radiation-induced strand break repair by cisplatin in mammalian cells. Int. J. Radiat. Biol. 74, 61\u201369. https:\/\/doi.org\/10.1080\/095530098141735 (1998).","journal-title":"Int. J. Radiat. Biol."},{"key":"39409_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cbi.2014.04.004","volume":"217","author":"S KouassSahbani","year":"2014","unstructured":"KouassSahbani, S., Rezaee, M., Cloutier, P., Sanche, L. & Hunting, D. J. Non-DSB clustered DNA lesions induced by ionizing radiation are largely responsible for the loss of plasmid DNA functionality in the presence of cisplatin. Chem. Biol. Interact. 217, 9\u201318. https:\/\/doi.org\/10.1016\/j.cbi.2014.04.004 (2014).","journal-title":"Chem. Biol. Interact."},{"key":"39409_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jphotobiol.2006.01.008","volume":"84","author":"A Wojcik","year":"2006","unstructured":"Wojcik, A. et al. DNA interstrand crosslinks are induced in cells prelabelled with 5-bromo-2-deoxyuridine and exposed to UVC radiation. J. Photochem. Photobiol. B 84, 15\u201320 (2006).","journal-title":"J. Photochem. Photobiol. B"},{"key":"39409_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/ctm.ctm_69_16","volume":"3","author":"W Zhao","year":"2017","unstructured":"Zhao, W., Li, Y. & Zhang, X. Stemness-related markers in cancer. Cancer Transl. Med. 3, 87\u201395. https:\/\/doi.org\/10.4103\/ctm.ctm_69_16 (2017).","journal-title":"Cancer Transl. Med."},{"key":"39409_CR36","doi-asserted-by":"publisher","first-page":"891652","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"TB Emran","year":"2022","unstructured":"Emran, T. B. et al. Multidrug resistance in cancer: Understanding molecular mechanisms, immunoprevention and therapeutic approaches. Front. Oncol. 12, 891652. https:\/\/doi.org\/10.3389\/fonc.2022.891652 (2022).","journal-title":"Front. Oncol."},{"key":"39409_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0165-1161(84)90020-7","volume":"130","author":"IC Enninga","year":"1984","unstructured":"Enninga, I. C., Groenendijk, R. T., van Zeeland, A. A. & Simons, J. W. Use of low temperature for growth arrest and synchronization of human diploid fibroblasts. Mutat. Res. 130, 343\u2013352. https:\/\/doi.org\/10.1016\/0165-1161(84)90020-7 (1984).","journal-title":"Mutat. Res."},{"key":"39409_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/03014460801908439","volume":"35","author":"RF Burton","year":"2008","unstructured":"Burton, R. F. Estimating body surface area from mass and height: Theory and the formula of Du Bois and Du Bois. Ann. Hum. Biol. 35, 170\u2013184. https:\/\/doi.org\/10.1080\/03014460801908439 (2008).","journal-title":"Ann. Hum. Biol."},{"key":"39409_CR39","first-page":"A. 3B. 1","volume":"21","author":"W Strober","year":"1997","unstructured":"Strober, W. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol.ogy 21, A. 3B. 1-2 (1997).","journal-title":"Curr. Protoc. Immunol.ogy"},{"key":"39409_CR40","doi-asserted-by":"publisher","first-page":"e51998","DOI":"10.3791\/51998","volume":"20","author":"S Borowicz","year":"2014","unstructured":"Borowicz, S. et al. The soft agar colony formation assay. J. Vis. Exp. 20, e51998. https:\/\/doi.org\/10.3791\/51998 (2014).","journal-title":"J. Vis. Exp."},{"key":"39409_CR41","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/09553002.2014.894650","volume":"90","author":"S Chandna","year":"2014","unstructured":"Chandna, S. et al. Agarose overlay selectively improves macrocolony formation and radiosensitivity assessment in primary fibroblasts. Int. J. Radiat. Biol. 90, 401\u2013406 (2014).","journal-title":"Int. J. Radiat. Biol."},{"key":"39409_CR42","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1667\/RR14803.1","volume":"188","author":"A Sollazzo","year":"2017","unstructured":"Sollazzo, A. et al. Alpha particles and X rays interact in inducing DNA damage in U2OS cells. Radiat. Res. 188, 400\u2013411 (2017).","journal-title":"Radiat. Res."},{"key":"39409_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/09553000601170469","volume":"83","author":"E Markova","year":"2007","unstructured":"Markova, E., Schultz, N. & Belyaev, I. Kinetics and dose-response of residual 53BP1\/\u03b3-H2AX foci: Co-localization, relationship with DSB repair and clonogenic survival. Int. J. Radiat. Biol. 83, 319\u2013329 (2007).","journal-title":"Int. J. Radiat. Biol."},{"key":"39409_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1383-5718(02)00249-8","volume":"534","author":"M Fenech","year":"2003","unstructured":"Fenech, M. et al. HUMN project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat. Res. 534, 65\u201375 (2003).","journal-title":"Mutat. Res."},{"key":"39409_CR45","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"39409_CR46","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3109\/09553002.2014.905725","volume":"90","author":"L Lundholm","year":"2014","unstructured":"Lundholm, L., H\u00e5\u00e5g, P., Juntti, T., Lewensohn, R. & Viktorsson, K. Phosphoprotein analysis reveals MEK inhibition as a way to target non-small cell lung cancer tumor initiating cells. Int. J. Radiat. Biol. 90, 718\u2013726 (2014).","journal-title":"Int. J. Radiat. Biol."},{"key":"39409_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"T-C Chou","year":"1984","unstructured":"Chou, T.-C. & Talalay, P. Quantitative analysis of dose\u2013effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22, 27\u201355 (1984).","journal-title":"Adv. Enzyme Regul."},{"key":"39409_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"T-C Chou","year":"2010","unstructured":"Chou, T.-C. Drug combination studies and their synergy quantification using the Chou\u2013Talalay method synergy quantification method. Can. Res. 70, 440\u2013446 (2010).","journal-title":"Can. Res."},{"key":"39409_CR49","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"J Cohen","year":"1988","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences (Lawrence Erlbaum Associates, 1988)."},{"key":"39409_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12978-021-01131-w","volume":"18","author":"A Ciapponi","year":"2021","unstructured":"Ciapponi, A., Belizan, J. M., Piaggio, G. & Yaya, S. There is life beyond the statistical significance. Reprod. Health 18, 80. https:\/\/doi.org\/10.1186\/s12978-021-01131-w (2021).","journal-title":"Reprod. Health"},{"key":"39409_CR51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41586-019-00857-9","volume":"567","author":"V Amrhein","year":"2019","unstructured":"Amrhein, V., Greenland, S. & McShane, B. Scientists rise up against statistical significance. Nature 567, 305\u2013307. https:\/\/doi.org\/10.1038\/d41586-019-00857-9 (2019).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39409-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39409-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T08:35:13Z","timestamp":1700555713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-39409-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39409"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-39409-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2567040\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,9]]},"assertion":[{"value":"9 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14891"}}